Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 2529 entries
View as:

Comparison of the Effects of Indacaterol and Tiotropium on Inspiratory Capacity

Phase: N/A Priority: Normal
NCT ID: NCT00999908 Org: User:
Start: 10/31/09 End: 03/31/10 Due: 03/31/11

Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients

Phase: N/A Priority: Normal
NCT ID: NCT02435849 Org: User:
Start: 04/08/15 End: 11/17/22 Due: 11/17/23

A Study to Evaluate the Efficiency of Intravenously Administered Cyclosporine in de Novo Liver Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00332462 Org: User:
Start: 05/31/06 End: 01/31/09 Due: 01/31/10

Renal Hemodynamic Effects of RLX030A in Subjects With Chronic Heart Failure (CHF)

Phase: N/A Priority: Normal
NCT ID: NCT01546532 Org: User:
Start: 02/29/12 End: 12/31/12 Due: 12/31/13

Valsartan Intensified Primary Care Reduction of Blood Pressure Study

Phase: N/A Priority: Normal
NCT ID: NCT00902304 Org: User:
Start: 07/31/09 End: 07/31/11 Due: 07/31/12

Real-world Evaluation of the Impact of Baseline Metastases on Clinical Outcomes Among BRAF Positive Metastatic Melanoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT05984615 Org: User:
Start: 06/08/22 End: 08/24/22 Due: 08/24/23

Study of Efficacy and Safety of Dabrafenib Plus Trametinib in Previously Treated Patients With Locally Advanced or Metastatic, Radio-active Iodine Refractory BRAFV600E Mutation-positive Differentiated Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04940052 Org: User:
Start: 11/15/21 End: 05/26/27 Due: 05/26/28

Modifying PEST for Psoriatic Arthritis Screening

Phase: N/A Priority: Normal
NCT ID: NCT06382051 Org: User:
Start: 01/23/25 End: 08/31/25 Due: 08/31/26

A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa

Phase: N/A Priority: Normal
NCT ID: NCT06799000 Org: User:
Start: 01/31/25 End: 10/20/28 Due: 10/20/29

A Study of Rapcabtagene Autoleucel in Systemic Lupus Erythematosus (SLE) Patients With Active, Refractory Lupus Nephritis (LN)

Phase: N/A Priority: Normal
NCT ID: NCT06581198 Org: User:
Start: 09/04/24 End: 06/07/33 Due: 06/07/34

Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.

Phase: N/A Priority: Normal
NCT ID: NCT02792231 Org: User:
Start: 08/26/16 End: 10/22/20 Due: 10/22/21

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QAX576 in Asthma Patients

Phase: N/A Priority: Normal
NCT ID: NCT00940160 Org: User:
Start: 07/31/09 End: - Due: -

Study Assessing the Efficacy, Safety and PK of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum

Phase: N/A Priority: Normal
NCT ID: NCT04589650 Org: User:
Start: 04/19/21 End: 02/14/31 Due: 02/14/32

Effects of Aliskiren, Ramipril, and the Combination on Levels of Angiotensin II in Patients With Decompensated Systolic Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT00923156 Org: User:
Start: 05/31/09 End: 02/28/11 Due: 02/28/12

Safety and Efficacy of QAW039 in Sputum Eosinophilia and Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01545726 Org: User:
Start: 02/29/12 End: 06/30/13 Due: 06/30/14

Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02826603 Org: User:
Start: 06/22/16 End: 07/09/18 Due: 07/09/19

Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS

Phase: N/A Priority: Normal
NCT ID: NCT03066648 Org: User:
Start: 07/06/17 End: 09/08/23 Due: 09/08/24

Burden of Illness and Treatment Assessment of Patients With Dry Eye Disease: A Cross-Sectional Survey of Real-World Patients With Dry Eye Disease in the US

Phase: N/A Priority: Normal
NCT ID: NCT06018571 Org: User:
Start: 06/02/22 End: 08/19/22 Due: 08/19/23

Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00099229 Org: User:
Start: 11/30/04 End: 08/31/06 Due: 08/31/07

Study to Investigate Safety, Pharmacokinetic (PK), Pharmacodynamic (PD) and Clinical Activity of Trametinib in Subjects With Cancer or Plexiform Neurofibromas and Trametinib in Combination With Dabrafenib in Subjects With Cancers Harboring V600 Mutations

Phase: N/A Priority: Normal
NCT ID: NCT02124772 Org: User:
Start: 01/15/15 End: 12/29/20 Due: 12/29/21

INC280 in Healthy Subjects With Impaired Hepatic Function and Subjects With Normal Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT02474537 Org: User:
Start: 06/12/15 End: 09/12/17 Due: 09/12/18

Study of Safety and Efficacy of BCL201 and Idelalisib in Patients With FL and MCL

Phase: N/A Priority: Normal
NCT ID: NCT02603445 Org: User:
Start: 11/16/15 End: 07/10/18 Due: 07/10/19

Study of Efficacy, Safety and Tolerability of AIN457 in Patients With Active Overuse Tendinopathy

Phase: N/A Priority: Normal
NCT ID: NCT03344640 Org: User:
Start: 12/15/17 End: 10/17/19 Due: 10/17/20

Safety and Efficacy of Imatinib Mesylate in Patients With Pulmonary Arterial Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00477269 Org: User:
Start: 04/30/06 End: 01/31/14 Due: 01/31/15

A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251

Phase: N/A Priority: Normal
NCT ID: NCT02449018 Org: User:
Start: 04/30/15 End: 01/23/17 Due: 01/23/18